Skip to main content

Articles By Rachel Tate, DO

RWCS 2021 card

RWCS Highlights - Day 4

By Rachel Tate, DO
16 February 2021

As another year at RWCS in Maui wrapped up, I’m so thankful I had the opportunity to participate remotely. Here are my day 4 #RWCS2021 pearls from the Novel Therapies Year in Review (RA, SLE, OA); novel concepts in pediatric rheumatology; and post-COVID telerheumatology sessions.

Read Article
rwcsmtg.jpeg

RWCS Highlights - Day 3

By Rachel Tate, DO
15 February 2021

Day 3 report from the 2021 RWCS meeting in Maui (and virtually) includes pearls from the PsA 2020 Year in Review; fact vs. fiction on evidence based medicine: diet and rheumatic diseases; hot topics in allergy/immunology; and pediatric rheumatology highlights.

Read Article
fellows.RWCS_.JPG

RWCS Highlights - Day 2

By Rachel Tate, DO
12 February 2021

As I attend RWCS virtually, I am always amazed by the amount of thought that goes into preparing great talks geared toward busy clinicians. Today, I am highlighting a few more pearls that you may find interesting as well.

Read Article
RWCS 2021

RWCS Highlights - Day 1

By Rachel Tate, DO
11 February 2021

The 2021 Rheumatology Winter Clinical Symposium launched yesterday as a hybrid meeting. As always, this conference lends itself to data for the practical clinician. Here are my pearls about new developments in RA, checkpoint inhibitors and IV IgG taken from several sessions presented on Day 1.

Read Article
covid vaccine needle vaccination

ACIP Recommendations for Pfizer Vaccine Candidate

By Rachel Tate, DO
07 December 2020

The CDC advisory panel, ACIP, has voted and declared that the first wave of vaccines should go to the front line healthcare workers and elderly residents in long term care facilities as part of Phase1a. The decision was not unanimous.

Read Article
vaccination_0.jpg

The Vaccine Review Process and why you should know it

By Rachel Tate, DO
16 November 2020

There is much controversy regarding vaccine safety and efficacy in the United States. Prior to COVID19, there were populations who lacked confidence in vaccination for any number of reasons. Dr.

Read Article
covid19.logo__0.jpg

Six Things Rheumatologists Need to Know About COVID-19

By Rachel Tate, DO
06 November 2020

From flu shots and face masks to vaccines and searching for the immunological endotype, here are six things rheumatologists need to know about COVID-19.

Read Article
antibody

Rapid Loss of SARS-CoV-2 Antibodies in Mild Disease

By Rachel Tate, DO
23 July 2020

According to a small, observational study out of UCLA published as correspondence in the NEJM on July 21, 2020, those with mild COVID-19 symptoms showed an approximate antibody half-life of 73 days. COVID-19 infection was confirmed by PCR in 30 out of 34 study participants. The remaining four patients developed consistent symptoms and cohabitated with a person who had a known positive test but could not get testing due to availability or mild symptoms.

Read Article
boat sunrise

Reprioritizing your mental health

By Rachel Tate, DO
23 June 2020

With a global pandemic, protests, fake news, real news, politics, home schooling, quarantine, and constant change to our day to day lives looming, the time to reprioritize is now. We need to step up for our patients, staff, loved ones, and ourselves. This week, I challenge you to reconsider how your mental health affects not only your life, but those of everyone around you.

Read Article
sea%20of%20rheumatolgy_0.jpg

Best of 2019 - Why Rheumatologists are the Happiest

By Rachel Tate, DO
25 December 2019

It’s hard work wearing a crown. The dermatologists have been dethroned as Medscape’s happiest specialty after years at the top. While studies only detail that we are the most satisfied outside of work, I argue we are the happiest working, too. With an N of 1, here are my 10 observations.

Read Article
×